0001209191-22-015869.txt : 20220303 0001209191-22-015869.hdr.sgml : 20220303 20220303183919 ACCESSION NUMBER: 0001209191-22-015869 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Healy John Stephen CENTRAL INDEX KEY: 0001908071 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 22711102 MAIL ADDRESS: STREET 1: C/O TYRA BIOSCIENCES, INC. STREET 2: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-03-01 0 0001863127 Tyra Biosciences, Inc. TYRA 0001908071 Healy John Stephen C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 0 1 0 0 General Counsel and Secretary Stock Option (Right to Buy) 2.25 2021-03-09 Common Stock 51948 D Stock Option (Right to Buy) 10.75 2031-06-23 Common Stock 134937 D Stock Option (Right to Buy) 24.15 2031-11-01 Common Stock 83626 D Stock Option (Right to Buy) 24.15 2031-11-01 Common Stock 7964 D Stock Option (Right to Buy) 24.15 2031-11-01 Common Stock 7964 D 1/48th of the shares subject to the option vest monthly following February 26, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. 25% of the shares subject to the option shall vest on March 5, 2022, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. 1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The option vests based on achievement of a performance objective. /s/ John Stephen Healy 2022-03-03